Navigation Links
ThermoGenesis Appoints Chief Executive Officer J. Melville ('Mel') Engle to Board of Directors
Date:6/10/2009

RANCHO CORDOVA, Calif., June 10 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products for processing and storing adult stem cells, said today that J. Melville Engle, the Company's Chief Executive Officer, has been appointed to its board of directors. His appointment brings the total number of directors to six.

Engle, who has more than 30 years of management experience in the healthcare industry, joined the Company as Chief Executive Officer in April 2009.

"In his short time at ThermoGenesis, Mel has demonstrated strong leadership skills and has implemented initiatives to continue the Company's turnaround strategy. We look forward to his contributions as a member of the board," said Dr. Hubert Huckel, Chairman of the Board of Directors.

"I appreciate this recognition from our board and look forward to even further collaboration with them as ThermoGenesis realizes its growth strategies. I continue to be excited about the Company's prospects, based on its technology leadership, track record of product innovation and the growing stem cell market opportunity," Engle noted. "The initial response to our new MarrowXpress(TM) (MXP) used to prepare cell concentrates from bone marrow has been positive, and we are looking forward to the pending launch of the Res-Q(TM), a point-of-care device for the bone marrow market," he added.

Prior to joining ThermoGenesis, Engle was Chief Executive Officer of Raydiance, Inc., a laser technology company. For six years he served as President and Chief Executive Officer of Dey LP, a $600 million specialty pharmaceutical company, an affiliate of Merck KGaA. While at Dey, he served as Regional Director, North America, for the Merck Generics Group. He also served as Chairman, President and Chief Executive Officer of Anika Thera
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
2. ThermoGenesis Corp. Reports First Quarter 2008 Results
3. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
4. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
5. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
6. ThermoGenesis Reports First Quarter 2009 Results
7. ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
8. ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition
9. ThermoGenesis Corp. Provides Updated Information for Conference Call/Webcast to Discuss Management Transition
10. ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention
11. Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Lesbian, Gay, Bisexual and Transgender (LGBT) Pride ... sexual minority youth are still at greater ... according to the Suicide Prevention Resource Center. ... recently published recommendation to improve psychologists, treatment ... improve psychological functioning and reduce depression and ...
(Date:6/18/2013)... 2013)-- An international team of investigators co-led by Weill ... evidence-based surgery and device research, similar to the kind ... , "Currently, there is no dynamic research framework to ... benefits to patients or may even be harmful," says ... College. , In the June 18 issue of ...
(Date:6/18/2013)... FL (PRWEB) June 18, 2013 There ... best education for students around the country. Some of ... life is enriched by the areas or region. The ... the benefits of attending one of these hidden gems ... show informs viewers of the educational facilities with better ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Dr. Farooq ... the Atlanta Vision Institute, is pleased to announce that ... generation of Intralase LASIK equipment, the iFS™ Advanced Femtosecond ... LASIK practice in Atlanta to offer its patients this ... is giving his patients a complimentary upgrade to the ...
(Date:6/18/2013)... New York, NY (PRWEB) June 18, 2013 ... to protecting the rights of consumers, has filed a ... central air conditioner units from 2007 and onward under ... evaporator coils . The lawsuit was filed on May ... District of Florida (Case No. 8:13-cv-1213T17TBM). Goodman Global Inc., ...
Breaking Medicine News(10 mins):Health News:Sexual minority youth need specialized treatment from therapists 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3Health News:Editions TV Presents a Segment on the Higher Education Hidden Gems 2Health News:Atlanta LASIK Surgeon Offers New LASIK Technology 2Health News:Goodman and Amana Air Conditioners Allegedly Violated Consumer Warranties, Charges Class Action Lawsuit Filed by Parker Waichman LLP 2
... Their own funds for the treatment of their thalassaemic daughter ... braving the odds to spread awareness about the disease.// ... district. Before tying the knot, they didn't know how thalassaemia ... the importance of a premarital blood detection test and initiated ...
... Lebanon, a Mediterranean country, is considered notoriously image-conscious. It may ... militants// clashing fiercely all the time. ,But the ... ,Only that should explain why the Fist National Bank ... surgery. ,Its website dubs the 'plastic surgery loans' ...
... [CNS] in animal evolution has puzzled scientists for centuries. ... but their CNSs are different and were thought to ... evolution. Researchers from the European Molecular Biology Laboratory [EMBL] ... is probably much older than expected. The study, which ...
... Thomas Jefferson University Hospital are combining efforts to determine if ... forms of migraine headaches. ,Investigators from the Jefferson ... in a blinded study to determine if closing a Patent ... allow blood to flow between the right and left sides ...
... up its socks on health issues, lest it pay a ... diseases’. If the present trend continues//, 66% of deaths by ... ,A study conducted by Assocham and Price Waterhouse Coopers (PwC) ... vulnerability of the Indian population to cardiovascular disease. It is ...
... foods and toys it is the turn of beef products ... following fears of E coli outbreak. Four of the five ... ,E. coli, or Escherichia coli, is a common ... cramps, fever, bloody diarrhea, kidney failure, blindness, paralysis and sometimes ...
Cached Medicine News:Health News:Thalassaemic Child's Parents Campaign for Awareness 2Health News:Loans for Cosmetic Surgery in Lebanon 2Health News:The Origin of the Brain Lies in a Worm 2Health News:Jefferson Researchers Want to Learn If Heart Defect 'at Heart' of Some Migraines 2Health News:E Coli Outbreak Forces Large-scale Recall of Beef Products 2
(Date:6/18/2013)... -- Royal Philips (NYSE: PHG, AEX: PHIA) ... in Imaging Equipment in the 2013 Best in KLAS ... Best in KLAS and Best in Category awards for ... Computed Tomography (CT), Ingenia 1.5T and 3.0T Magnetic Resonance ... Best in KLAS Awards: Medical Imaging & Infrastructure are ...
(Date:6/18/2013)... YORK, Pa. , June 18, 2013 ... a U.S. based designer, developer and manufacturer of injectable ... new corporate website at www.unilife.com . The new ... information, with updates to occur on a regular basis. ... of Unilife, stated, "As an emerging global leader for ...
(Date:6/18/2013)... Calif. , June 18, 2013  Women are ... families, but unfortunately they often do not give the ... women have kept information from their doctor because they ... it, according to a recent survey conducted by Allergan ... organization dedicated to bringing education, funding and research to ...
Breaking Medicine Technology:Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Unilife Launches New Corporate Website 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 4New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 5New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 6New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 7New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 8New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 9
... Dec. 10 The US Food and,Drug Administration ... small,open, long-term, clinical studies in patients with gastro-esophageal ... study) or NEXIUM(R) (LOTUS study) treatment., AstraZeneca ... conclusion which states,"FDA continues to conclude that long-term ...
... 3 Results Released at American Society of Hematology ... Genta,Incorporated (Nasdaq: GNTA ) announced the release ... patients in the Company,s randomized Phase,3 trial of ... lymphocytic leukemia (CLL). The new data show that,patients ...
Cached Medicine Technology:FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 3FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 2Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 3Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 5Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 6
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: